Genomic Cancer Medicine
Sarcomas are devastating cancers that arise in the connective tissues – bone, muscle, fat, cartilage. They account for 1% of all cancer, but up to 20% of cancers in children and young adults. My lab is interested in the germline and somatic genetics of sarcomas, as well as cancers more broadly in young adults.
We use patient-centred approaches to understanding human disease, complemented with cellular and animal models to explore biological processes relevant to cancer. We have a particular focus on generating informative cohorts of patients and families affected by cancer, and applying state-of-the-art genomic technologies to understanding why some individuals are affected by cancer, and how cancers evolve.
More recently, we have become interested in developing innovative strategies to translate insights generated using basic research tools into opportunities to help patients and their families. These approaches include pilot programs for risk modification for individuals who are prone to cancer, aimed at early detection and better treatment; and at innovations in clinical trials that will increase access of cancer patients to new therapies.
In the News
YOUNG GARVAN EDGY IDEAS AWARDS NIGHT - Oct 06, 2017
Ground-breaking trial brings personalised treatments to those with rare cancers - Aug 23, 2017
Top-to-toe MRI screen picks up early-stage cancers while still curable - Aug 04, 2017
NHMRC: grants success for Garvan researchers - Dec 05, 2016
Awareness of fifth most common cause of cancer related death in Australia is alarmingly low - Nov 08, 2016
Beyond ‘single-gene thinking’: Garvan researchers uncover complex genetic secrets of cancer risk - Aug 05, 2016
NHMRC funding success for Garvan researchers - Nov 09, 2015
Fashion heavyweights join forces to support Garvan for Fashion Targets Breast Cancer - Aug 14, 2015
Scientists solve mystery of ‘Frankenstein’ DNA - Nov 11, 2014
David Thomas appointed as new Director of The Kinghorn Cancer Centre - Dec 19, 2013